DK2156840T3 - Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme - Google Patents

Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme

Info

Publication number: DK2156840T3
Authority: DK; Denmark
Prior art keywords: treatment; mometasone furoate; respiratory; pulmonary diseases; allergic
Prior art date: 1994-01-27

Application number

DK09007995.5T

Other languages

English (en)

Inventor

Joel A Sequeira

Francis M Cuss

Keith B Nolop

Imtiaz A Chaudry

Nagamani Nagabhushan

James E Patrick

Mitchell Cayen

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-01-27

Filing date

1995-01-26

Publication date

2011-11-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22692858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2156840(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-01-26 Application filed by Schering Corp filed Critical Schering Corp

2011-11-21 Application granted granted Critical

2011-11-21 Publication of DK2156840T3 publication Critical patent/DK2156840T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Otolaryngology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK09007995.5T 1994-01-27 1995-01-26 Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme DK2156840T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18837294A	1994-01-27	1994-01-27
EP01119613A EP1174138B1 (en)	1994-01-27	1995-01-26	Use of mometasone furoate for treating airway passage and lung diseases

Publications (1)

Publication Number	Publication Date
DK2156840T3 true DK2156840T3 (da)	2011-11-21

Family

ID=22692858

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK95909242T DK0740550T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfurat til behandling af sygdomme i luftveje og lunger
DK09007995.5T DK2156840T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme
DK01119613.6T DK1174138T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK95909242T DK0740550T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfurat til behandling af sygdomme i luftveje og lunger

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK01119613.6T DK1174138T3 (da)	1994-01-27	1995-01-26	Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme

Country Status (29)

Country	Link
EP (6)	EP1174139B1 (da)
JP (6)	JP3480736B2 (da)
KR (1)	KR100234864B1 (da)
CN (4)	CN100441192C (da)
AT (5)	ATE519489T1 (da)
AU (1)	AU691880B2 (da)
CA (1)	CA2182086C (da)
CO (1)	CO4340692A1 (da)
CY (2)	CY2616B2 (da)
CZ (1)	CZ219196A3 (da)
DE (1)	DE69526425T2 (da)
DK (3)	DK0740550T3 (da)
ES (3)	ES2173947T3 (da)
FI (2)	FI122395B (da)
HK (4)	HK1040911B (da)
HU (1)	HU227837B1 (da)
IL (1)	IL112459A (da)
MX (1)	MX9602246A (da)
MY (1)	MY114665A (da)
NO (2)	NO314535B1 (da)
NZ (1)	NZ279979A (da)
PE (1)	PE44995A1 (da)
PL (1)	PL315575A1 (da)
PT (3)	PT740550E (da)
SG (1)	SG47387A1 (da)
SK (1)	SK283338B6 (da)
TW (1)	TW329387B (da)
WO (1)	WO1995020393A1 (da)
ZA (1)	ZA95637B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE44995A1 (es) *	1994-01-27	1995-12-18	Schering Corp	Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
WO1997042958A1 (en) *	1996-05-09	1997-11-20	Amrad Operations Pty. Ltd.	Treatment of asthma and airway diseases
PE100198A1 (es) *	1996-08-29	1999-01-11	Schering Corp	Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos
US6068832A (en) *	1996-08-29	2000-05-30	Schering Corporation	Chlorofluorocarbon-free mometasone furoate aerosol formulations
US5968547A (en)	1997-02-24	1999-10-19	Euro-Celtique, S.A.	Method of providing sustained analgesia with buprenorphine
DE69828155T2 (de) *	1997-03-20	2005-12-22	Schering Corp.	Herstellung von pulveragglomeraten
US6495167B2 (en)	1997-03-20	2002-12-17	Schering Corporation	Preparation of powder agglomerates
US6503537B2 (en)	1997-03-20	2003-01-07	Schering Corporation	Preparation of powder agglomerates
WO1999018971A1 (en) *	1997-10-09	1999-04-22	Schering Corporation	Mometasone furoate suspensions for nebulization
MY133181A (en) *	1998-09-10	2007-10-31	Schering Corp	Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
GB9904919D0 (en)	1999-03-03	1999-04-28	Novartis Ag	Organic compounds
SE9900833D0 (sv) *	1999-03-09	1999-03-09	Astra Ab	Novel combination
ES2284531T3 (es) *	1999-10-08	2007-11-16	Schering Corporation	Tratamiento nasal topico usando desloratadina y furoato de mometasona.
ECSP003747A (es) *	1999-11-02	2002-05-23	Smithkline Beecham Corp	Metodo y composiciones para el tratamiento de las enfermedades pulmonares
GB0015876D0 (en)	2000-06-28	2000-08-23	Novartis Ag	Organic compounds
WO2002011711A2 (en) *	2000-08-04	2002-02-14	Longwood Pharmaceutical Research, Inc.	Formulations of mometasone and a bronchodilator for pulmonary administration
CA2438799C (en) *	2000-12-22	2009-09-01	Ssp Co., Ltd.	Preventative of therapeutic agent for inflammatory respiratory tract disease
GB0207906D0 (en)	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and mometasone aerosol formulations
MXPA06003376A (es) *	2003-09-26	2006-06-08	Schering Corp	Tratamiento de enfermedad pulmonar.
WO2005037245A2 (en) *	2003-10-21	2005-04-28	Direct-Haler A/S	A multiple route medication for the treatment of rhinitis and asthma
CA2543482A1 (en) *	2003-10-28	2005-05-19	Glaxo Group Limited	Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
EP2201936B1 (en) *	2004-01-21	2013-06-19	Merck Sharp & Dohme Corp.	Method of treating acute rhinosinusitis
JP4893999B2 (ja) *	2004-10-22	2012-03-07	小野薬品工業株式会社	吸入用医薬組成物
US8324192B2 (en)	2005-11-12	2012-12-04	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en)	2005-11-12	2014-03-25	The Regents Of The University Of California	Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
KR101245604B1 (ko)	2007-11-13	2013-03-21	메리테이지 파마, 인크.	코르티코스테로이드 조성물
US20090131386A1 (en)	2007-11-13	2009-05-21	Meritage Pharma, Inc.	Compositions for the treatment of inflammation of the gastrointestinal tract
US9623000B2 (en)	2008-07-31	2017-04-18	Dekel Pharmaceuticals Ltd	Compositions and methods for treating inflammatory disorders
PL2328553T3 (pl) *	2008-08-20	2020-12-14	The Regents Of The University Of California	Kortykosteroidy do leczenia chorób zapalnych przewodu pokarmowego
AU2009302362A1 (en) *	2008-10-10	2010-04-15	Merck Sharp & Dohme Corp.	Corticosteroid compositions for use in treating diseases of the upper and lower airway passages
US9937189B2 (en)	2013-09-13	2018-04-10	Glenmark Specialty S.A.	Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US9370483B2 (en)	2013-09-13	2016-06-21	Glenmark Specialty S.A.	Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US10016443B2 (en)	2013-10-04	2018-07-10	Glenmark Specialty S.A.	Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10758550B2 (en)	2013-10-04	2020-09-01	Glenmark Specialty S.A.	Treatment of allergic rhinitis using a combination of mometasone and olopatadine
RU2686670C2 (ru)	2013-10-04	2019-04-30	Гленмарк Спешиалити С.А.	Лечение аллергического ринита с использованием комбинации мометазона и олопатадина
US10548907B2 (en)	2013-10-04	2020-02-04	Glenmark Specialty S.A.	Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10653661B2 (en)	2013-10-04	2020-05-19	Glenmark Specialty S.A.	Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US11679210B2 (en)	2014-10-03	2023-06-20	Glenmark Specialty S.A.	Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN107260665B (zh) *	2016-04-08	2021-03-30	天津金耀集团有限公司	一种吸入用糠酸莫米松混悬液组合物
SG11202112592YA (en)	2018-02-23	2021-12-30	Glenmark Specialty Sa	Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine
US12303635B2 (en)	2018-04-16	2025-05-20	Glenmark Specialty S.A.	Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN113933415B (zh) *	2021-09-30	2023-03-24	北京阳光德美医药科技有限公司	一种hplc-ms/ms测定人血浆中糠酸酯浓度的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3260474D1 (en)	1981-02-02	1984-09-06	Schering Corp	Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
KR890000664B1 (ko) *	1981-10-19	1989-03-22	바리 안소니 뉴우샘	미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4731447A (en)	1985-05-13	1988-03-15	Schering Corporation	Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof
US4972830A (en)	1985-07-31	1990-11-27	Vortran Medical Technology, Inc.	Inhalation device and method
US4873335A (en)	1986-03-12	1989-10-10	Schering Corporation	3-phenethyl-2-benzene-amides or aza-derivatives thereof
US4910192A (en) *	1987-12-04	1990-03-20	Sri International	Topically active steroidal anti-inflammatory agents
DE69027319T2 (de) *	1989-04-28	1996-11-21	Riker Laboratories Inc., Northridge, Calif.	Inhalationsvorrichtung für trockenpulver
AU654813B2 (en) *	1990-03-23	1994-11-24	Minnesota Mining And Manufacturing Company	The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
PL165803B1 (pl) *	1990-09-10	1995-02-28	Schering Corp	Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL
CA2091354C (en) *	1990-10-16	2005-04-12	John Lezdey	Treatment of inflammation
ES2064160T3 (es) *	1990-10-18	1995-01-16	Minnesota Mining & Mfg	Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
GB9105705D0 (en) *	1991-03-18	1991-05-01	Sandoz Ltd	Improvements in or relating to organic compounds
ATE203902T1 (de) *	1991-06-10	2001-08-15	Schering Corp	Fluorchlorkohlenwasserstofffreie aerosolformulierungen
ATE132368T1 (de) *	1991-06-10	1996-01-15	Schering Corp	Fluorchlorkohlenwasserstoffreie aerosolformulierungen
ZA924718B (en)	1991-06-26	1993-02-24	Schering Corp	Inhalation device for powdered medicaments
DE4140689B4 (de) *	1991-12-10	2007-11-22	Boehringer Ingelheim Kg	Inhalationspulver und Verfahren zu ihrer Herstellung
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
DE69205177T2 (de) *	1991-12-12	1996-03-21	Glaxo Group Ltd., Greenford, Middlesex	Pharmazeutische Aerosolformulierung.
ES2123576T3 (es) *	1991-12-12	1999-01-16	Glaxo Group Ltd	Medicamentos.
JP2736168B2 (ja) *	1992-03-10	1998-04-02	フアイソンズ・ピーエルシー	医薬製剤
GB9207400D0 (en) *	1992-04-02	1992-05-13	Smithkline Beecham Plc	Novel use
PE44995A1 (es) *	1994-01-27	1995-12-18	Schering Corp	Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

1995
- 1995-01-24 PE PE1995260142A patent/PE44995A1/es not_active Application Discontinuation
- 1995-01-26 AT AT09007995T patent/ATE519489T1/de active
- 1995-01-26 ZA ZA95637A patent/ZA95637B/xx unknown
- 1995-01-26 SK SK822-96A patent/SK283338B6/sk not_active IP Right Cessation
- 1995-01-26 SG SG1996000423A patent/SG47387A1/en unknown
- 1995-01-26 AT AT02001144T patent/ATE531364T1/de active
- 1995-01-26 EP EP01119614A patent/EP1174139B1/en not_active Expired - Lifetime
- 1995-01-26 CO CO95002738A patent/CO4340692A1/es unknown
- 1995-01-26 DK DK95909242T patent/DK0740550T3/da active
- 1995-01-26 CA CA002182086A patent/CA2182086C/en not_active Expired - Lifetime
- 1995-01-26 EP EP02001144A patent/EP1201242B1/en not_active Expired - Lifetime
- 1995-01-26 TW TW084100705A patent/TW329387B/zh not_active IP Right Cessation
- 1995-01-26 EP EP09007995A patent/EP2156840B1/en not_active Expired - Lifetime
- 1995-01-26 NZ NZ279979A patent/NZ279979A/en not_active IP Right Cessation
- 1995-01-26 CN CNB2004100324736A patent/CN100441192C/zh not_active Expired - Lifetime
- 1995-01-26 KR KR1019960704076A patent/KR100234864B1/ko not_active Expired - Lifetime
- 1995-01-26 CN CNA2007101867131A patent/CN101156860A/zh active Pending
- 1995-01-26 EP EP01119613A patent/EP1174138B1/en not_active Expired - Lifetime
- 1995-01-26 MX MX9602246A patent/MX9602246A/es active IP Right Grant
- 1995-01-26 HU HU9602043A patent/HU227837B1/hu unknown
- 1995-01-26 PT PT95909242T patent/PT740550E/pt unknown
- 1995-01-26 PT PT01119613T patent/PT1174138E/pt unknown
- 1995-01-26 IL IL11245995A patent/IL112459A/xx not_active IP Right Cessation
- 1995-01-26 AT AT01119614T patent/ATE525075T1/de not_active IP Right Cessation
- 1995-01-26 JP JP52007495A patent/JP3480736B2/ja not_active Expired - Lifetime
- 1995-01-26 EP EP01119615A patent/EP1192946A1/en not_active Ceased
- 1995-01-26 PT PT09007995T patent/PT2156840E/pt unknown
- 1995-01-26 EP EP95909242A patent/EP0740550B1/en not_active Expired - Lifetime
- 1995-01-26 CN CNB951913603A patent/CN100358528C/zh not_active Expired - Lifetime
- 1995-01-26 AU AU17271/95A patent/AU691880B2/en not_active Expired
- 1995-01-26 DE DE69526425T patent/DE69526425T2/de not_active Expired - Lifetime
- 1995-01-26 AT AT95909242T patent/ATE216243T1/de active
- 1995-01-26 PL PL95315575A patent/PL315575A1/xx unknown
- 1995-01-26 CN CNA2007101867146A patent/CN101164542A/zh active Pending
- 1995-01-26 DK DK09007995.5T patent/DK2156840T3/da active
- 1995-01-26 AT AT01119613T patent/ATE518520T1/de active
- 1995-01-26 ES ES95909242T patent/ES2173947T3/es not_active Expired - Lifetime
- 1995-01-26 ES ES01119613T patent/ES2368827T3/es not_active Expired - Lifetime
- 1995-01-26 CZ CZ962191A patent/CZ219196A3/cs unknown
- 1995-01-26 DK DK01119613.6T patent/DK1174138T3/da active
- 1995-01-26 WO PCT/US1995/000550 patent/WO1995020393A1/en active Application Filing
- 1995-01-26 ES ES09007995T patent/ES2369516T3/es not_active Expired - Lifetime
- 1995-01-27 MY MYPI95000213A patent/MY114665A/en unknown
1996
- 1996-07-12 FI FI962828A patent/FI122395B/fi not_active IP Right Cessation
- 1996-07-26 NO NO19963132A patent/NO314535B1/no not_active IP Right Cessation
1998
- 1998-11-30 JP JP10340817A patent/JPH11286447A/ja not_active Withdrawn
2002
- 2002-02-27 HK HK02101490.1A patent/HK1040911B/en not_active IP Right Cessation
- 2002-02-27 HK HK02101491.0A patent/HK1040912A1/en unknown
- 2002-04-08 HK HK02102575.7A patent/HK1040918A1/en unknown
- 2002-05-21 HK HK02103767.3A patent/HK1041829A1/en unknown
- 2002-10-17 NO NO20025002A patent/NO328698B1/no not_active IP Right Cessation
2003
- 2003-06-03 JP JP2003158657A patent/JP2003313128A/ja not_active Withdrawn
2007
- 2007-10-19 JP JP2007273211A patent/JP2008031184A/ja not_active Withdrawn
2008
- 2008-07-02 JP JP2008174020A patent/JP5247265B2/ja not_active Expired - Lifetime
2011
- 2011-07-08 FI FI20115742A patent/FI123580B/fi not_active IP Right Cessation
- 2011-10-27 CY CY1100006A patent/CY2616B2/xx unknown
- 2011-10-27 CY CY1100007A patent/CY2617B2/xx unknown
- 2011-11-09 JP JP2011245814A patent/JP2012036222A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
AU1727195A (en)	1995-08-15
DE69526425D1 (de)	2002-05-23
EP2156840A3 (en)	2010-05-19
HK1135331A1 (en)	2010-06-04
PL315575A1 (en)	1996-11-12
CZ219196A3 (en)	1996-12-11
ATE525075T1 (de)	2011-10-15
CA2182086A1 (en)	1995-08-03
HK1040918A1 (en)	2002-06-28
MX9602246A (es)	1997-07-31
CN1531967A (zh)	2004-09-29
EP1174139A2 (en)	2002-01-23
JPH11286447A (ja)	1999-10-19
ATE518520T1 (de)	2011-08-15
PT740550E (pt)	2002-08-30
EP1201242A3 (en)	2003-12-03
FI122395B (fi)	2011-12-30
EP1174138B1 (en)	2011-08-03
TW329387B (en)	1998-04-11
NO20025002D0 (no)	2002-10-17
DK1174138T3 (da)	2011-11-21
KR100234864B1 (ko)	1999-12-15
HK1040911A1 (en)	2002-06-28
DE69526425T2 (de)	2002-12-05
EP1192946A1 (en)	2002-04-03
SK82296A3 (en)	1997-03-05
ATE519489T1 (de)	2011-08-15
NO963132L (no)	1996-09-26
HK1040912A1 (en)	2002-06-28
HU9602043D0 (en)	1996-09-30
CY2616B2 (en)	2012-05-23
EP1174139B1 (en)	2011-09-21
JP2003313128A (ja)	2003-11-06
CO4340692A1 (es)	1996-07-30
FI123580B (fi)	2013-07-31
CN100441192C (zh)	2008-12-10
ATE531364T1 (de)	2011-11-15
FI962828A0 (fi)	1996-07-12
HK1041829A1 (en)	2002-07-26
JP3480736B2 (ja)	2003-12-22
JP2008285497A (ja)	2008-11-27
ZA95637B (en)	1995-07-26
CY2617B2 (en)	2012-05-23
EP1201242A2 (en)	2002-05-02
DK0740550T3 (da)	2002-06-24
AU691880B2 (en)	1998-05-28
CN1139384A (zh)	1997-01-01
JP2012036222A (ja)	2012-02-23
JPH09501700A (ja)	1997-02-18
EP0740550B1 (en)	2002-04-17
PT2156840E (pt)	2011-10-18
CN101156860A (zh)	2008-04-09
ES2173947T3 (es)	2002-11-01
NZ279979A (en)	2001-03-30
CN100358528C (zh)	2008-01-02
IL112459A0 (en)	1995-03-30
FI20115742L (fi)	2011-07-08
ES2369516T3 (es)	2011-12-01
SG47387A1 (en)	1998-04-17
WO1995020393A1 (en)	1995-08-03
NO328698B1 (no)	2010-04-26
NO963132D0 (no)	1996-07-26
JP5247265B2 (ja)	2013-07-24
ATE216243T1 (de)	2002-05-15
EP1174139A3 (en)	2002-01-30
PT1174138E (pt)	2011-10-03
ES2368827T3 (es)	2011-11-22
NO20025002L (no)	1996-09-26
MY114665A (en)	2002-12-31
CN101164542A (zh)	2008-04-23
HUT74884A (en)	1997-02-28
HK1040911B (en)	2011-11-18
HU227837B1 (en)	2012-05-02
EP2156840A2 (en)	2010-02-24
EP0740550A1 (en)	1996-11-06
JP2008031184A (ja)	2008-02-14
PE44995A1 (es)	1995-12-18
EP2156840B1 (en)	2011-08-10
EP1174138A3 (en)	2002-01-30
SK283338B6 (sk)	2003-06-03
EP1174138A2 (en)	2002-01-23
CA2182086C (en)	2000-04-11
IL112459A (en)	1999-04-11
FI962828L (fi)	1996-07-12
NO314535B1 (no)	2003-04-07
EP1201242B1 (en)	2011-11-02

Publication	Publication Date	Title
DK1174138T3 (da)	2011-11-21	Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme
CY1109030T1 (el)	2014-07-02	Συνθεση για εισπνοη
Janssens et al.	2003	Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model
DE60002885D1 (de)	2003-06-26	Wässrige formulierung zur nasalen verabreichung
Blanco et al.	2001	AD Loppow et al.
Heath et al.	1998	Information from your family doctor: Taking care of chronic bronchitis
WO1992011025A3 (en)	1992-09-17	Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases